Germany - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Germany Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale fell by 4.9% year on year. With €718,679,434.78 in 2019, the country was ranked number 4 comparing other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Germany is overtaken by Italy, which was ranked number 3 at €1,184,225,798.77 and is followed by France with €642,378,032.96. Denmark ranked the highest with €3,801,340,964.3 in 2019, a decrease of 2.9% compared to 2018. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 718,679,434.78
2018 728,531,245.00
2017 734,208,641.00
2016 732,961,746.00
2015 653,987,241.00
Download all data from 1995 to 2019

How does Germany rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
3 #3
Italy
1,184,225,798.77 2019 -18.6 % +51.6 % View data
4 #4
Germany
718,679,434.78 2019 -1.4 % -4.9 % View data
5 #5
France
642,378,032.96 2019 +2.7 % -2.6 % View data
Compare all 16 countries

Go Top